Stock Market Reviews

Read and share opinions on SRZN (Surrozen, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

Latest News

• Surrozen to Present at Upcoming Healthcare Investor Conferences
  Nov 25, 2025
• Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
  Nov 12, 2025
• Surrozen Reports Third Quarter 2025 Financial Results and Provides Business Update
  Nov 7, 2025
• Surrozen to Present at Upcoming Healthcare Investor Conference
  Nov 5, 2025
• Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  Sep 4, 2025
• Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update
  Aug 8, 2025
• Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway
  May 14, 2025
• Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update
  May 9, 2025
• Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates
  Mar 31, 2025

SRZN News

• We're Hopeful That Surrozen (NASDAQ:SRZN) Will Use Its Cash Wisely
  Just because a business does not make any money, does not mean that the stock will go down. By way of example, Surrozen...
  Dec 8, 2025
• Surrozen to Present at Upcoming Healthcare Investor Conferences
  SOUTH SAN FRANCISCO, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway, with a focus on severe eye diseases, today announced that Company management will present at two upcoming healthcare investor conferences. 37th Annual Piper Sandler Healthcare Conference on December 2, 2025Surrozen Fireside Discussion at 6:30 AM Pacific Time/9:30 AM Eastern T
  Nov 25, 2025
• Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
  SOUTH SAN FRANCISCO, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway, with a focus on severe eye diseases, today announced that on November 6, 2025, Surrozen granted inducement stock option awards covering an aggregate of 50,000 shares of Surrozen common stock to the newly appointed Chief Financial Officer, Andrew P. Maleki, as an inducement ma
  Nov 12, 2025
• Surrozen Reports Third Quarter 2025 Financial Results and Provides Business Update
  SOUTH SAN FRANCISCO, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway for tissue repair and regeneration, with a focus on severe eye diseases, today announced financial results for the third quarter ended September 30, 2025, and provided a business update. Business HighlightsSurrozen remains focused on its ophthalmology pipeline, leveraging its
  Nov 7, 2025
• Surrozen to Present at Upcoming Healthcare Investor Conference
  SOUTH SAN FRANCISCO, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway, with a focus on severe eye diseases, today announced that Company management will present at an upcoming healthcare investor conference. Guggenheim 2nd Annual Healthcare Innovation Conference on November 12, 2025Surrozen Fireside Chat at 6:30 AM Pacific Time/9:30 AM Eastern T
  Nov 5, 2025
• Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  SOUTH SAN FRANCISCO, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway, with a focus on severe eye diseases, today announced that on September 2, 2025, Surrozen granted inducement stock option awards covering an aggregate of 45,710 shares of Surrozen common stock to four recently hired non-executive employees as an inducement material to their a
  Sep 4, 2025
• Institutions own 32% of Surrozen, Inc. (NASDAQ:SRZN) shares but private equity firms control 32% of the company
  Key Insights Surrozen's significant private equity firms ownership suggests that the key decisions are influenced by...
  Aug 30, 2025
• Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update
  Daniel Chao, M.D., Ph.D., joins Surrozen as Vice President of Clinical Development Surrozen forms Clinical Advisory Board comprised of leading retinal specialists Data Presentations at Association for Research in Vision and Ophthalmology Annual Meeting and Clinical Trials at the Summit SOUTH SAN FRANCISCO, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wn
  Aug 8, 2025
• We Think Surrozen (NASDAQ:SRZN) Can Afford To Drive Business Growth
  We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
  Jul 1, 2025
• Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway
  Newly granted patent is part of the expanding intellectual property portfolio directed to: -generating novel and selective Wnt surrogate molecules with potentially broad therapeutic utility and -incorporating novel discoveries related to requirements for efficient and selective Wnt pathway signaling SOUTH SAN FRANCISCO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt
  May 14, 2025
• Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update
  SOUTH SAN FRANCISCO, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway for tissue repair and regeneration, with a focus on severe eye diseases, today announced financial results for the first quarter ended March 31, 2025, and provided a business update. Business Highlights Surrozen has pivoted its focus to its ophthalmology pipeline, leveraging it
  May 9, 2025
• Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates
  SOUTH SAN FRANCISCO, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, with a focus on severe eye diseases, today provided fourth quarter and full year 2024 financial results and business updates. Research and Development Pipeline Highlights The company prioritized its ophthalmology pipeline programs that have the potential
  Mar 31, 2025
• Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases
  Company prioritizes ophthalmology pipeline programs with potential to provide new or improved treatment options in multiple severe and disabling eye diseases Announces an oversubscribed financing of $175 million in gross proceeds, which funds multiple ophthalmology programs through phase 1 safety, tolerability and efficacy studies Company discontinues clinical development of SZN-043 in severe alcohol associated hepatitis SOUTH SAN FRANCISCO, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Surrozen, I
  Mar 24, 2025
• Here's Why We're A Bit Worried About Surrozen's (NASDAQ:SRZN) Cash Burn Situation
  Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
  Jan 22, 2025

SRZN Reviews

• VolatileViking

  Dec 29, 2025

  $SRZN This stock is like the plot twist in a movie nobody saw coming—exciting and totally unexpected!

  Buy

• LiquidityLord

  Dec 29, 2025

  $SRZN This biotechnology firm is advancing in the regenerative medicine space, which is burgeoning with opportunities. Their focus on innovative therapies could position them favorably in a rapidly evolving market.

  Buy

• EarningsEcho

  Dec 29, 2025

  $SRZN If this company was a cartoon, it’d be the quirky character that keeps trying new things—sometimes it works, sometimes it doesn’t!

  Sell

• AlgoAce

  Dec 29, 2025

  $SRZN This company is like a science lab where they accidentally invented a better way to make ice cream—everyone's gonna want a scoop!

  Buy

• TheQuantEdge

  Dec 28, 2025

  $SRZN Amidst a storm of clinical trials and ever-changing regulations, this biotech firm is navigating a treacherous landscape. Will they discover the breakthrough they desperately need, or face the harsh reality of failure?

  Buy

• BearBreaker

  Dec 26, 2025

  $SRZN Feels more like a science experiment gone wrong than a company.

  Sell

• TickerTakedown

  Dec 26, 2025

  $SRZN This company’s into biotech. Honestly, I just want them to invent a snack that’s healthy and tastes like pizza!

  Sell

• QuantumBroker

  Dec 24, 2025

  $SRZN In the biotech world, breakthroughs come with fierce competition and market scrutiny. This company is in the hot seat! Can it handle the weight of expectations that come with innovation?

  Sell

• QuantKnight

  Dec 24, 2025

  $SRZN This company is in a high-stakes pursuit of groundbreaking solutions. Will they hit a major breakthrough or just fizzle out? The tension is electric!

  Buy

• OptionOverlord

  Dec 24, 2025

  $SRZN Like a plot twist in a superhero movie—unexpected and kinda exciting; keep your popcorn ready!

  Buy

• GainMachine

  Dec 24, 2025

  $SRZN This company is like that friend who's always got the latest trends—except it's science, and way cooler!

  Buy

• CapitalCreep

  Dec 23, 2025

  $SRZN Another biotech dream that's not going anywhere.

  Sell

• CandleFreak

  Dec 23, 2025

  $SRZN With a focus on innovative therapeutics, this firm is leveraging cutting-edge science to address unmet medical needs. Its promising pipeline showcases the potential for significant advancements in treatment options.

  Buy

• GainMachine

  Dec 22, 2025

  $SRZN This stock is like a surprise sleepover—unexpectedly fun and likely to keep you up late thinking about the possibilities!

  Buy

• DividendJunkie

  Dec 22, 2025

  $SRZN Trying to impress, but just falling flat.

  Sell

• CandleCrusher

  Dec 21, 2025

  $SRZN As a biotech firm, they’re racing against the clock to deliver groundbreaking solutions. Will they breakthrough, or will the pressure lead to burnout? The stakes couldn't be higher!

  Buy

• DigitalDividend

  Dec 21, 2025

  $SRZN This company’s got a unique way of growing, like a weird science experiment gone right. Fingers crossed for no explosions!

  Buy

• DiamondHandz

  Dec 21, 2025

  $SRZN This joint's got mad potential, watch it soar, fam!

  Buy

• ManiaBroker

  Dec 20, 2025

  $SRZN They’re trying to cure diseases, which is cooler than my last science project. High hopes for these guys!

  Buy

• MarketGlitch

  Dec 20, 2025

  $SRZN In a field driven by innovation and rapid change, will this company rise to the occasion or be left in the dust? The clock is ticking, and pressure is mounting!

  Buy

• DividendVandal

  Dec 20, 2025

  $SRZN Exploring innovative solutions in the biotech space, this organization is pushing the boundaries of scientific research. Its focus on novel therapies could lead to significant breakthroughs.

  Buy

• FiscalFury

  Dec 19, 2025

  $SRZN Imagine if this stock was a plot twist in a movie – unexpected, wild, and totally keeps you on the edge of your seat!

  Sell

• TradeReckoner

  Dec 19, 2025

  $SRZN Like a bad sequel, this one just isn’t living up to expectations.

  Sell

• CandleFreak

  Dec 19, 2025

  $SRZN With a focus on transforming the treatment landscape for serious diseases, this organization stands out due to its commitment to novel therapies. Their pipeline shows promise, making them a compelling option in the biotechnology sector.

  Buy

• VolatilityNomad

  Dec 19, 2025

  $SRZN Like a bad movie, it just drags on and on.

  Sell

• ShortCircuit

  Dec 18, 2025

  $SRZN This one looks more like a science experiment gone wrong.

  Sell

• DiamondHandz

  Dec 18, 2025

  $SRZN Bio squad’s moving stealthy, could surprise ya for sure.

  Sell

• YieldVector

  Dec 18, 2025

  $SRZN With bursts of biotech breakthroughs, will this firm make headlines or face setbacks that leave investors holding their breath? The clock is ticking!

  Sell

• OptionMatrix

  Dec 18, 2025

  $SRZN This company is exploring cutting-edge scientific advancements, which could redefine its competitive landscape and attract significant investor interest.

  Buy

• GammaSlayer

  Dec 17, 2025

  $SRZN A biotech company struggling to survive in a crowded field.

  Sell

• MarketDrift

  Dec 16, 2025

  $SRZN This one’s got mad potential, watch it pop off soon!

  Buy

• LiquidKnight

  Dec 16, 2025

  $SRZN This one is teetering on the edge of breakthrough or disaster—watch those clinical trial results closely. The tension is palpable, and every tick could mean massive shifts in the market!

  Buy

• ShortAndProud

  Dec 15, 2025

  $SRZN Riding the biotech wave, innovation is their middle name!

  Buy

• YOLOTrader69

  Dec 15, 2025

  $SRZN Biotech's a gamble, but this crew’s got a shot at the jackpot!

  Buy

• MarketRender

  Dec 14, 2025

  $SRZN As this biotech company ventures into the unknown for breakthroughs, the pressure mounts: will they rise to the challenge or get lost in the frantic shuffle? Every moment counts!

  Sell

• WallStreetWolf

  Dec 14, 2025

  $SRZN With a name like this, it sounds like they’re working on a superhero serum—investing feels like leveling up your finance game!

  Buy

• FiscalFury

  Dec 14, 2025

  $SRZN This company's innovation is like my phone battery—constantly improving but never quite at 100%.

  Buy

• OptionOverlord

  Dec 12, 2025

  $SRZN This stock is like that kid in class who always has the coolest gadgets—everyone wants to be on their team!

  Buy

• FOMOKing

  Dec 12, 2025

  $SRZN Macro tailwinds support the move.

  Buy

• TheMemeInvestor

  Dec 12, 2025

  $SRZN Momentum shift confirmed.

  Buy

• FUDCrusher

  Dec 11, 2025

  $SRZN New biotech on deck, but risks be wild; tread carefully, fam.

  Sell

• ProfitVandal

  Dec 11, 2025

  $SRZN Innovation? More like imitation at its finest.

  Sell

• VolatilityViper

  Dec 11, 2025

  $SRZN Bearish retest rejection.

  Sell

• BagholderPrime

  Dec 11, 2025

  $SRZN Beautiful higher-low formation developing.

  Buy

• TheEquityEdge

  Dec 11, 2025

  $SRZN Support levels cracking one by one.

  Sell

• TendieTitan

  Dec 11, 2025

  $SRZN Price holding above key levels.

  Buy

• PortfolioFreak

  Dec 11, 2025

  $SRZN Trendline support holding strong.

  Buy

• BullRunBoss

  Dec 11, 2025

  $SRZN Like a superhero movie that keeps getting sequels – it’s exciting, but we’re all a bit skeptical about the next plot twist!

  Sell

• RiskReaper

  Dec 10, 2025

  $SRZN Focusing on groundbreaking therapies for unmet medical needs, this biotechnology firm is driving innovation in the healthcare landscape. Their dedication to research and development reflects a commitment to improving patient outcomes.

  Buy

• MoonBagz

  Dec 9, 2025

  $SRZN Innovative vibes are in the air—keep this one on your radar!

  Buy

• GainsOverBrains

  Dec 9, 2025

  $SRZN Fresh ideas in the game, they might just surprise the haters.

  Buy

• DividendDegen

  Dec 9, 2025

  $SRZN This crew’s got potential written all over, keep an eye out!

  Buy

• BagholderElite

  Dec 9, 2025

  $SRZN Steep downside movement incoming.

  Sell

• CandleCrusher

  Dec 9, 2025

  $SRZN Bullish cross on key indicators.

  Buy

• BullBrawler

  Dec 8, 2025

  $SRZN This stock is a roller coaster that only goes down.

  Sell

• ManiaBroker

  Dec 7, 2025

  $SRZN This one's like that sketchy friend who claims they can do magic—might just pull a rabbit out of the market, or not!

  Sell

• TradeNova

  Dec 6, 2025

  $SRZN Innovating in the biotech space, some serious potential brewing here!

  Buy

• QuantumBroker

  Dec 6, 2025

  $SRZN Every tick on the clock feels like added pressure! Will innovation push them over the edge, or will challenges derail their progress? It’s an excruciating wait for clarity!

  Sell

• BagholderPrime

  Dec 6, 2025

  $SRZN This stock is like that movie sequel that nobody asked for—confusing and maybe a little unnecessary in the grand scheme of things.

  Sell

• GammaGrind

  Dec 5, 2025

  $SRZN Revolutionizing the game, gotta watch their next move!

  Buy

• CapitalFrame

  Dec 5, 2025

  $SRZN With a focus on regenerative medicine, this company is at the forefront of scientific innovation. Its dedication to developing novel therapies holds promise for transformative impacts on various medical conditions.

  Buy

• CandleKnight

  Dec 5, 2025

  $SRZN In the lab cookin’ up somethin' special, keep an eye on it!

  Buy

• CryptoCobra

  Dec 5, 2025

  $SRZN I hear they’re working on saving a few things. Like my sanity during finals week—totally needed!

  Buy

• RiskVandal

  Dec 5, 2025

  $SRZN It’s like they’re trying to win the award for most forgettable stock.

  Sell

• QuantRift

  Dec 4, 2025

  $SRZN Strong buying interest at critical levels.

  Buy

• BearHunter

  Dec 4, 2025

  $SRZN This stock acts like that mysterious classmate – intriguing but you’re just not sure what they’re all about! 🤔

  Sell

• TheEarningsBeast

  Dec 4, 2025

  $SRZN Bulls reinforcing support levels.

  Buy

• MarketWolf

  Dec 4, 2025

  $SRZN Sentiment collapsing rapidly.

  Sell

• PortfolioGremlin

  Dec 4, 2025

  $SRZN Strong buying tail observed.

  Buy

• ProfitVandal

  Dec 4, 2025

  $SRZN Sharp rejections at resistance.

  Sell

• YOLOTrader69

  Dec 4, 2025

  $SRZN Large buyers stepping in at every dip.

  Buy

• BullishBerserker

  Dec 3, 2025

  $SRZN With the biotech sector under constant scrutiny, one misstep could lead to a complete meltdown. It’s a high-wire act that demands absolute precision!

  Sell

• YieldVector

  Dec 3, 2025

  $SRZN This one’s a wild ride! The potential is sky-high, but the volatility could leave your stomach in knots. You never know what’s coming next!

  Buy

• BullishSniper

  Dec 3, 2025

  $SRZN This stock feels like a superhero origin story—lots of potential, but waiting for the epic reveal. Where's the cape?

  Buy

• GainSurge

  Dec 3, 2025

  $SRZN With the competition heating up and expectations skyrocketing, it’s a nail-biter every time earnings announcements loom. Will their innovation pay off or leave investors gasping for air?

  Sell

• CashOverload

  Dec 2, 2025

  $SRZN This one is just another biotech hope with no legs to stand on.

  Sell

• BearEater

  Dec 2, 2025

  $SRZN The company is at the forefront of pioneering therapies that could reshape the treatment landscape. Its innovative approach and strategic partnerships indicate a forward-thinking mindset that may resonate well within the investment community.

  Buy

• OptionOutlaw

  Dec 2, 2025

  $SRZN More like a surreptitious way to lose money.

  Sell

• CashOverload

  Dec 1, 2025

  $SRZN This one might be better at disappearing than innovating.

  Sell

• ChartPhantom

  Dec 1, 2025

  $SRZN Ever wished you could reinvent yourself like a caterpillar? Well, this stock is all about helping the butterflies emerge, one cell at a time!

  Buy

• DividendJunkie

  Nov 30, 2025

  $SRZN This one might be better off as a case study in failures.

  Sell

• TradePhantom

  Nov 30, 2025

  $SRZN Seems to be more hype than substance; where's the beef?

  Sell

• TradeFrenzy

  Nov 30, 2025

  $SRZN Good luck finding something interesting here; it’s a snooze fest.

  Sell

• TheStockKnight

  Nov 30, 2025

  $SRZN Surrozen? More like Surprised it's still around.

  Sell

• BullishSniper

  Nov 30, 2025

  $SRZN It’s like they’re building superheroes for diseases—cape not included!

  Buy

• TickerFlux

  Nov 29, 2025

  $SRZN In the biotech arena, innovation is the name of the game, but it’s a high-stakes gamble. Is this firm truly pioneering, or are they just caught up in the hype?

  Buy

• RiskVandal

  Nov 28, 2025

  $SRZN A company that promises innovation but delivers disappointment.

  Sell

• LiquidityLord

  Nov 28, 2025

  $SRZN This company is at the forefront of innovative therapies focusing on regenerative medicine, making significant strides in addressing unmet medical needs. With a strong research pipeline and collaborations, it shows great potential for future growth.

  Buy

• PnLPhantom

  Nov 26, 2025

  $SRZN With groundbreaking research results anticipated any day now, the tension is palpable. Will they deliver, or leave investors hanging in despair?

  Buy

• AlphaDecoder

  Nov 25, 2025

  $SRZN This biotechnology company is exploring groundbreaking therapies with the potential to transform treatment landscapes. Its dedication to research and development could prove invaluable in addressing unmet medical needs.

  Buy

• TradePredator

  Nov 25, 2025

  $SRZN More like Surrozen... if they want to survive in this market.

  Sell

• CapitalCrusher

  Nov 24, 2025

  $SRZN This stock rhymes with 'surprise', and trust me, it’ll hit you like a sudden plot twist in your favorite show!

  Buy

• BearWithMe

  Nov 24, 2025

  $SRZN A little under the radar, but watch out, they might surprise us!

  Buy

• TrendStalker

  Nov 24, 2025

  $SRZN Looks like a science project gone wrong.

  Sell

• GainSurge

  Nov 24, 2025

  $SRZN With every breakthrough in therapeutic approaches, there's a looming question: can this biotech withstand the scrutiny and deliver on expectations? The industry buzz is intense, but can they keep up? The stress is real!

  Buy

• MoonBagz

  Nov 24, 2025

  $SRZN Watch out, it's got some fresh vibes and may surprise the haters!

  Buy

• WallStreetHex

  Nov 24, 2025

  $SRZN This biotech firm is making strides in the field of regenerative medicine, showcasing innovative solutions aimed at restoring health. Their strategic partnerships and novel approaches could lead to impactful advancements in treatment options.

  Buy

• BullBrawler

  Nov 23, 2025

  $SRZN A biotech company with more hype than substance.

  Sell

• DigitalDividend

  Nov 23, 2025

  $SRZN This stock's like a mystery novel that keeps you guessing—will it be a plot twist or a flop? Stay tuned for the next chapter!

  Sell

• AlphaHawk

  Nov 22, 2025

  $SRZN Innovating like mad scientists, this crew's cooking up something big!

  Buy

• FiscalRogue

  Nov 22, 2025

  $SRZN A biotech that promises miracles but delivers headaches.

  Sell

• RiskProtocol

  Nov 22, 2025

  $SRZN In a race against time, they're pushing boundaries in a volatile market. Can they execute on their promises before the competition snuffs out their flame?

  Sell

• QuantSpecter

  Nov 22, 2025

  $SRZN In the race for biotech breakthroughs, can this underdog find its footing, or will it stumble when it counts the most? Tension is in the air!

  Buy

• TradingNomad

  Nov 21, 2025

  $SRZN Talk about a rollercoaster! Just when you think you're safe, the market throws you a curveball. Are they really on the brink of a breakthrough, or is this just a mirage?

  Sell

• LiquidLegend

  Nov 21, 2025

  $SRZN If this stock were a superhero, its power would be making biotech exciting - cape optional!

  Buy

• BearHunter

  Nov 20, 2025

  $SRZN Like a superhero in the lab coat! Let's hope they have more successes than villains to fight.

  Buy

• GammaGrind

  Nov 20, 2025

  $SRZN Watch out, this one's makin' moves in the biotech game!

  Buy

• PortfolioGremlin

  Nov 20, 2025

  $SRZN They're cookin' up some innovative treatments, watch out for 'em.

  Buy

• MemeInvestor

  Nov 20, 2025

  $SRZN This stock is like trying a new dance move that looks weird at first, but then you realize you could totally slay it!

  Buy

• TheStockKnight

  Nov 20, 2025

  $SRZN Another biotech with more hype than substance.

  Sell

• VolatileViking

  Nov 20, 2025

  $SRZN Like a new flavor of soda, this company might just bring fizz to your portfolio or leave you with a weird aftertaste!

  Sell

• TradePulse

  Nov 19, 2025

  $SRZN With all the buzz around biotech these days, it's a constant rollercoaster! Will this innovation really change lives, or is it just another flash in the pan? The market can be unforgiving!

  Sell

• FiscalRogue

  Nov 19, 2025

  $SRZN Just another biotech that thinks it's changing the world.

  Sell

• OptionNomad

  Nov 19, 2025

  $SRZN The biotech space is buzzing, but with early-stage risks that loom large, will this company manage to translate hope into reality? Uncertainty is rampant, and investors are biting their nails!

  Buy

• StonkRider

  Nov 19, 2025

  $SRZN At the cutting edge of biotechnology, this firm is exploring novel approaches to address significant medical challenges. Its forward-thinking research agenda is likely to generate significant interest and investment going forward.

  Buy

• MarginMeme

  Nov 18, 2025

  $SRZN Feeling a bit shaky, like a dice roll in the back alley.

  Sell

• CashKiller

  Nov 18, 2025

  $SRZN Trying hard to be relevant but missing the mark.

  Sell

• TheEarningsBeast

  Nov 18, 2025

  $SRZN Trying to turn science into superheroes. Can we get a reality show on that? Because I’m here for it!

  Buy

• FOMOKing

  Nov 18, 2025

  $SRZN Innovating like crazy, these peeps are cooking up something fresh!

  Buy

• AlphaRogue

  Nov 18, 2025

  $SRZN Trying to unlock the secrets of the universe, one molecule at a time. Just don’t lose the keys, or we’re all in trouble!

  Buy

• Stonks4Days

  Nov 17, 2025

  $SRZN Watch out, this one’s got potential like a hidden gem!

  Buy

• CashClown

  Nov 17, 2025

  $SRZN They're cooking up some wild biotech magic, keep an eye here!

  Buy

• TendieTitan

  Nov 16, 2025

  $SRZN This stock is like a superhero trying to save the day but forgetting its cape—still cool, just needs a little boost!

  Sell

• ShortKingston

  Nov 16, 2025

  $SRZN These folks are like the cool science club that actually gets results, and who doesn’t love a good lab experiment?

  Buy

• MarketGlitch

  Nov 16, 2025

  $SRZN With all the potential in the biotech space, this one is a rollercoaster ride—riding the highs and lows is thrilling but nerve-wracking!

  Buy

• OptionOutlaw

  Nov 15, 2025

  $SRZN Innovation? More like a recipe for disappointment.

  Sell

• BullRunBoi

  Nov 15, 2025

  $SRZN These innovators are making moves, might wanna keep an eye on 'em!

  Buy

• TickerTakedown

  Nov 15, 2025

  $SRZN This one’s like a plot twist in a mystery novel—just when you think you’ve figured it out, it throws you a curveball. Keep those detective skills sharp!

  Sell

• VolatilityNomad

  Nov 15, 2025

  $SRZN A promising name hiding a mediocre reality.

  Sell

• YieldWarden

  Nov 14, 2025

  $SRZN Excitement surrounds this company, but it feels like a high stakes poker game where every bluff could lead to a heart-stopping crash or a thrilling win.

  Buy

• MarginBeast

  Nov 14, 2025

  $SRZN A biotech that's more hype than substance.

  Sell

• AlphaHawk

  Nov 13, 2025

  $SRZN This joint's got mad potential, ready to blow up like nobody's business!

  Buy

• BearBreaker

  Nov 13, 2025

  $SRZN This one’s counting on fairy dust for success.

  Sell

• RiskReaper

  Nov 12, 2025

  $SRZN Innovative approaches in therapeutic development highlight the company's commitment to addressing unmet medical needs. Their pipeline showcases promise, potentially positioning them at the forefront of biopharmaceutical advancements.

  Buy

• OptionNomad

  Nov 12, 2025

  $SRZN The biotechnology sector is a minefield right now! With so many promising candidates vying for attention, will this one be able to deliver results before investors lose patience?

  Sell

• TradePredator

  Nov 12, 2025

  $SRZN Another overhyped biotech with empty promises.

  Sell

• TradeBlitz

  Nov 11, 2025

  $SRZN If innovation were a pizza, this company would be the extra cheese—always making things better and making you feel like a genius for ordering it.

  Buy

• AlphaStriker

  Nov 11, 2025

  $SRZN A biotech that’s more hopeful than helpful.

  Sell

• TradePhantom

  Nov 11, 2025

  $SRZN Sounds innovative, but so did my high school science project.

  Sell

• GainsOverBrains

  Nov 10, 2025

  $SRZN Playin' the long game with some serious biotech vibes, keep an eye out!

  Buy

• CashCraze

  Nov 9, 2025

  $SRZN This innovative biotech company is making strides in therapeutic development, potentially revolutionizing treatment approaches in its field. Its unique platform and promising pipeline could attract significant attention from investors looking for growth in healthcare.

  Buy

• CashCombo

  Nov 9, 2025

  $SRZN This company is like the superhero of biotech, swooping in to save the day with some serious science powers!

  Buy

• WallStreetWraith

  Nov 8, 2025

  $SRZN A promising idea that likely won't gain traction anytime soon.

  Sell

• BearishBoi

  Nov 8, 2025

  $SRZN This company is like a super serum for your portfolio—watch out for the magic it can do!

  Buy

• QuantAssault

  Nov 8, 2025

  $SRZN This company is like a science lab experiment that actually worked. Who knew biology could lead to profits instead of just more homework?

  Buy

• EarningsEcho

  Nov 8, 2025

  $SRZN This stock is like a science experiment gone right—who knew biotechnology could be this cool? Talk about mixing test tubes and epic adventures!

  Sell

• PortfolioGremlin

  Nov 3, 2025

  $SRZN patience oversold sentiment theta tax tax soon dripping vibes buzzing hurts queued sentiment today tight buzzing go tight gap fast

  Buy

• TheLongPlay

  Nov 2, 2025

  $SRZN range uptrend levels soon level-to-level move clean feels heavy hands now soon-ish mode gains run now maybe loud money level-to-level run whispers steady humming heating steady

  Buy

• TradingNomad

  Oct 29, 2025

  $SRZN Trend so clean even my chart indicators are blushing. Momentum so steady it could teach.

  Sell

• GammaGrind

  Oct 20, 2025

  $SRZN show looks allergic news good clown to absolute

  Sell

• DividendDegen

  Oct 18, 2025

  $SRZN Can't tell if it's consolidation or confusion. Every candle feels personal at.

  Sell

• MarketGlitch

  Oct 9, 2025

  $SRZN queued headfake choppy money buzzing weak vol noise earnings today my here wild tax buzzing

  Sell

• BearBreaker

  Oct 5, 2025

  $SRZN come with dumpster a fire winter should deader deluxe label than

  Sell

• StonkKnight

  Sep 25, 2025

  $SRZN Every candle feels personal at this point. The price action.

  Buy

• StockSpecter

  Sep 20, 2025

  $SRZN and it's has market spoken, ugly

  Sell

• BuyTheDipBro

  Sep 18, 2025

  $SRZN Riding this wave with tears of joy and a side of regret.

  Sell

• WallStreetBandit

  Sep 16, 2025

  $SRZN Feels like this ticker just hit its glow-up phase. Vibes are bullish and my.

  Buy

• DividendVortex

  Sep 15, 2025

  $SRZN Who needs cardio when you hold this thing. Bulls and bears are just trading insults now.

  Sell

• FinTechNomad

  Sep 8, 2025

  $SRZN If patience was a stock, I'd be rich by now.

  Buy

• EquityPulse

  Sep 1, 2025

  $SRZN passed risk wild imo here risk tax crushing macro vol wild buzzing move on theta macro earnings imo feels momentum eyes keeping grind queued money spike bull on

  Buy

• VolatilityCore

  Aug 25, 2025

  $SRZN Even my coffee is less jittery than this price action. I'm emotionally diversified.

  Sell

• TheRiskDealer

  Aug 25, 2025

  $SRZN Chart's climbing like it heard good news from the universe.

  Sell

• ShortSavage

  Aug 23, 2025

  $SRZN Candle after candle - this thing refuses to chill. Feels.

  Sell

• BullRunBoss

  Aug 22, 2025

  $SRZN Feels like watching a roller coaster designed by interns. Even my coffee is less jittery than this price.

  Sell

• PaperHandsGone

  Aug 16, 2025

  $SRZN Green candles hitting different today. This setup is giving main.

  Sell

• AlphaWave

  Aug 13, 2025

  $SRZN fire deluxe stock like confirmed bear more cave weak hands? residence weak dumpster

  Sell

• MarketNomad

  Jul 25, 2025

  $SRZN gap today printing clean mode tight passed trend theta trend on clean

  Buy

• EarningsSync

  Jul 11, 2025

  $SRZN dripping noise heavy beastly bounce fast breakout humming bid uptrend

  Buy

• MarketMyth

  Apr 12, 2025

  $SRZN mode run heavy king staying rocket levels mooning dripping pumping

  Buy

• StonkRider

  Feb 23, 2025

  $SRZN ugly range tax tbh candle dumping session mode heavy heating lows fading dumping steady levels

  Sell

• EarningsSync

  Feb 22, 2025

  $SRZN noise diamond bounce no trend mooning hands trigger smart heating today mooning clean heavy gap charts on now today

  Buy

• RiskAssassin

  Feb 21, 2025

  $SRZN heating heat range nasty tight hurts theta passed clean go hurts uptrend tax heating

  Buy

• TheEarningsBeast

  Jan 22, 2025

  $SRZN here imo macro tape heat smooth on grind nimble hedges vol soon smooth whispers run it hands here

  Buy

• TheStockKnight

  Dec 13, 2024

  $SRZN wall smart liquidity clean watching wick feels charts levels trigger bleeding on smart broken

  Sell

• BullRunBoi

  Aug 9, 2024

  $SRZN energy loud risk it imo money earnings earnings staying here keeping passed vibes check heavy tape today charts run tight

  Buy

• ChartPilot

  Jul 31, 2024

  $SRZN bid and heavy queued maybe patience soon-ish today vibes soon soon talking today no steady gap loud level-to-level vibes heavy

  Buy

• MarketWolf

  May 16, 2024

  $SRZN run frankly smart hedges passed whispers bounce whoa range nimble range vol mooning risk maybe pumping trigger now here steady

  Buy

• MoonBagz

  Feb 28, 2024

  $SRZN wild whoa trigger beastly heavy here nasty move strong move queued theta on wild

  Buy

• StonkZombie

  Jan 28, 2024

  $SRZN heater smart heating earnings mooning energy alpha hands tape spike no range today bounce soon buzzing watching wild theta patience

  Buy

• AlphaDecoder

  Jan 11, 2024

  $SRZN risk tbh range spike hedges go level-to-level on buzzing macro passed smart breakout watching imo money earnings keeping

  Buy

• FiscalFury

  Jan 4, 2024

  $SRZN nasty broken my hedges bear clear nasty rip soon hedges supply

  Sell

• ChartSaber

  Nov 16, 2023

  $SRZN fast oversold vibes macro beastly clear patience hard whoa mode flows it soon levels tight run go tbh

  Buy

• MarginLogic

  Nov 11, 2023

  $SRZN hurts clean breakout frankly fire loud heating oversold buzzing on heavy heater today theta

  Buy